TERF2_MOUSE - dbPTM
TERF2_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TERF2_MOUSE
UniProt AC O35144
Protein Name Telomeric repeat-binding factor 2
Gene Name Terf2
Organism Mus musculus (Mouse).
Sequence Length 541
Subcellular Localization Nucleus . Chromosome, telomere . Colocalizes with telomeric DNA in interphase cells and is located at chromosome ends during metaphase.
Protein Description Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes. In addition to its telomeric DNA-binding role, required to recruit a number of factors and enzymes required for telomere protection, including the shelterin complex, TERF2IP/RAP1 and DCLRE1B/Apollo. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded 5'-TTAGGG-3' repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Together with DCLRE1B/Apollo, plays a key role in telomeric loop (T loop) formation by generating 3' single-stranded overhang at the leading end telomeres: T loops have been proposed to protect chromosome ends from degradation and repair. Required both to recruit DCLRE1B/Apollo to telomeres and activate the exonuclease activity of DCLRE1B/Apollo. Preferentially binds to positive supercoiled DNA. Together with DCLRE1B/Apollo, required to control the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B) needed for telomere replication during fork passage and prevent aberrant telomere topology. Recruits TERF2IP/RAP1 to telomeres, thereby participating in to repressing homology-directed repair (HDR), which can affect telomere length..
Protein Sequence MAAGAGTAGPASGPGVVRDPMASQPRKRPSREGGEGGEGERRSNTMAGGGGSSDSSGRAASRRASRSGGRARRGRHEPGLGGAAERGAGEARLEEAVNRWVLKFYFHEALRAFRSSRYRDFRQIRDIMQALLVRPLGKEHTVSRLLRVMQCLSRIEEGENLDCSFDMEAELTPLESAINVLEMIKTEFTLTDSMVESSRKLVKEAAVIICIKNKEFEKASKILKKYMSKDPTTQKLRTDLLNIIREKNLAHPVIQNFSYEVFQQKMLRFLESHLDDTEPYLLTMAKKALKSESAASSTMREEKHPEPVEKPLREPPSRQPQNPPATIGIRTLKAAFKALSTAQDSEAAFAKLDQKDLVLANLASPSSPAHKHKRPRKDEHESAAPAEGEGGSDRQPRNSPMTISRLLLEEDSQSTEPSPGLNSSHKAMSASKPRALNQPHPGEKKPKASKDKWNSPNGLEEKEVWLEEDQLFEVQAPGEDRSSSLTRKQKWTIEESEWVKDGVRKYGEGNWAAISKSYPFVNRTAVMIKDRWRTMKKLGMN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
30PhosphorylationSQPRKRPSREGGEGG
CCCCCCCCCCCCCCC
47.1724704852
62Asymmetric dimethylarginineSSGRAASRRASRSGG
CHHHHHHHHHHHHCC
33.20-
62MethylationSSGRAASRRASRSGG
CHHHHHHHHHHHHCC
33.20-
63MethylationSGRAASRRASRSGGR
HHHHHHHHHHHHCCC
34.13-
172PhosphorylationFDMEAELTPLESAIN
CCCEEEECCHHHHHH
19.8225521595
198PhosphorylationTDSMVESSRKLVKEA
CHHHHHHHHHHHHHE
21.6725521595
214AcetylationVIICIKNKEFEKASK
EEEEECCHHHHHHHH
59.807614115
218AcetylationIKNKEFEKASKILKK
ECCHHHHHHHHHHHH
64.38155905
233PhosphorylationYMSKDPTTQKLRTDL
HHCCCCCHHHHHHHH
29.15-
337AcetylationRTLKAAFKALSTAQD
HHHHHHHHHHHCCCC
43.6322826441
340PhosphorylationKAAFKALSTAQDSEA
HHHHHHHHCCCCHHH
26.9317203969
341PhosphorylationAAFKALSTAQDSEAA
HHHHHHHCCCCHHHH
29.2317203969
364PhosphorylationLVLANLASPSSPAHK
HHHHHCCCCCCCCCC
28.6027087446
366 (in isoform 2)Phosphorylation-46.5919144319
366PhosphorylationLANLASPSSPAHKHK
HHHCCCCCCCCCCCC
46.5925177544
367PhosphorylationANLASPSSPAHKHKR
HHCCCCCCCCCCCCC
29.5027087446
392PhosphorylationPAEGEGGSDRQPRNS
CCCCCCCCCCCCCCC
40.2427841257
399PhosphorylationSDRQPRNSPMTISRL
CCCCCCCCCCCHHHH
19.8225521595
402PhosphorylationQPRNSPMTISRLLLE
CCCCCCCCHHHHHHH
21.1328833060
404PhosphorylationRNSPMTISRLLLEED
CCCCCCHHHHHHHCC
14.0122802335
412PhosphorylationRLLLEEDSQSTEPSP
HHHHHCCCCCCCCCC
29.3425266776
414PhosphorylationLLEEDSQSTEPSPGL
HHHCCCCCCCCCCCC
38.3926643407
415PhosphorylationLEEDSQSTEPSPGLN
HHCCCCCCCCCCCCC
44.2525266776
418PhosphorylationDSQSTEPSPGLNSSH
CCCCCCCCCCCCCHH
25.9321183079
423PhosphorylationEPSPGLNSSHKAMSA
CCCCCCCCHHHHHHC
38.5722802335
424PhosphorylationPSPGLNSSHKAMSAS
CCCCCCCHHHHHHCC
28.1222802335
429PhosphorylationNSSHKAMSASKPRAL
CCHHHHHHCCCCCHH
33.9622802335
455PhosphorylationASKDKWNSPNGLEEK
CCCCCCCCCCCCCCC
20.7328066266
484PhosphorylationPGEDRSSSLTRKQKW
CCCCCCCCCCCCCCE
34.7019854140

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
233TPhosphorylationKinaseATMQ62388
Uniprot
367SPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TERF2_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TERF2_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HEXI1_HUMANHEXIM1physical
26496610
TE2IP_HUMANTERF2IPphysical
26496610
DCR1B_HUMANDCLRE1Bphysical
26496610
TATD3_HUMANTATDN3physical
26496610
SH319_HUMANSH3D19physical
26496610

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TERF2_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale phosphorylation analysis of mouse liver.";
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND MASSSPECTROMETRY.
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry.";
Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.;
J. Proteome Res. 6:250-262(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND MASSSPECTROMETRY.

TOP